Decoy

Last updated
Carved, wooden duck decoys Decoys.jpg
Carved, wooden duck decoys

A decoy (derived from the Dutch dekooi, literally "the cage" [1] or possibly ende kooi, "duck cage" [2] ) is usually a person, device, or event which resembles what an individual or a group might be looking for, but it is only meant to lure them. Decoys have been used for centuries most notably in game hunting, but also in wartime and in the committing or resolving of crimes.

Contents

Illustration demonstrating the use of a dog in a duck decoy tunnel (1886) Decoy in action.png
Illustration demonstrating the use of a dog in a duck decoy tunnel (1886)

Hunting

In hunting wildfowl, the term decoy may refer to two distinct devices. One, the duck decoy (structure), is a long cone-shaped wickerwork tunnel installed on a small pond to catch wild ducks. After the ducks settled on the pond, a small, trained dog would herd the birds into the tunnel. The catch was formerly sent to market for food, but now these are used only by ornithologists to catch ducks to be ringed and released. The word decoy, also originally found in English as "coy", derives from the Dutch de Kooi (the cage) and dates back to the early 17th century, when this type of duck trap was introduced to England from the Netherlands. As "decoy" came more commonly to signify a person or a device than a pond with a cage-trap, the latter acquired the retronym "decoy pool".[ citation needed ]

The other form, a duck decoy (model), otherwise known as a 'decoy duck', 'hunting decoy' or 'wildfowl decoy', is a life-size model of the creature. The hunter places a number about the hunting area as they will encourage wild birds to land nearby, hopefully within the range of the concealed hunter. Originally carved from wood, they are now typically made from plastic.

Wildfowl decoys (primarily ducks, geese, shorebirds, and crows, but including some other species) are considered a form of folk art. Collecting decoys has become a significant hobby both for folk art collectors and hunters. The world record was set in September 2007 when a pintail drake and Canada goose, both by A. Elmer Crowell, sold for 1.13 million dollars apiece. [3] [4]

Military decoy

An inflatable dummy tank modeled after an M4 Sherman DummyShermanTank.jpg
An inflatable dummy tank modeled after an M4 Sherman

The decoy in war is a low-cost device intended to represent a real item of military equipment.

They may be used in different ways:

Bomb decoy

In irregular warfare, improvised explosive devices are commonly used as roadside bombs to target military patrols. Some guerrillas also use imitation IEDs to intimidate civilians, [5] to waste bomb disposal resources, [6] or to set up an ambush. [7] [8] [9] Some terrorist groups use fake bombs during a hostage siege, in order to limit hostage rescue efforts. [10] [11] [12]

Sonar decoy

A sonar decoy is a device designed to create a misleading reading on sonar, such as the appearance of a false target.

In biochemistry

In biochemistry, there are decoy receptors, decoy substrates and decoy RNA. In addition, digital decoys are used in protein folding simulations.

Decoy receptor

Decoy receptors, or sink receptors, [13] are receptors that bind a ligand, inhibiting it from binding to its normal receptor. For instance, the receptor VEGFR-1 can prevent vascular endothelial growth factor (VEGF) from binding to the VEGFR-2 [13] The TNF inhibitor etanercept exerts its anti-inflammatory effect by being a decoy receptor that binds to TNF. [14]

Decoy substrate

A decoy substrate or pseudosubstrate is a protein that has similar structure to the substrate of an enzyme, in order to make the enzyme bind to the pseudosubstrate rather than to the real substrate, thus blocking the activity of the enzyme. These proteins are therefore enzyme inhibitors.

Examples include K3L produced by vaccinia virus, which prevents the immune system from phosphorylating the substrate eIF-2 by having a similar structure to eIF-2. Thus, the vaccinia virus avoids the immune system.

Digital decoys

In protein folding simulations, a decoy is a computer-generated protein structure which is designed so to compete with the real structure of the protein. Decoys are used to test the validity of a protein model; the model is considered correct only if it is able to identify the native state configuration of the protein among the decoys.

Decoys are generally used to overcome a main problem in protein folding simulations: the size of the conformational space. For very detailed protein models, it can be practically impossible to explore all the possible configurations to find the native state. To deal with this problem, one can make use of decoys. The idea behind this is that it is unnecessary to search blindly through all possible conformations for the native conformation; the search can be limited to a relevant sub-set of structures. To start with, all non-compact configurations can be excluded. A typical decoy set will include globular conformations of various shapes, some having no secondary structures, some having helices and sheets in different proportions. The computer model being tested will be used to calculate the free energy of the protein in the decoy configurations. The minimum requirement for the model to be correct is that it identifies the native state as the minimum free energy state (see Anfinsen's dogma).

See also

Related Research Articles

<span class="mw-page-title-main">Enzyme</span> Large biological molecule that acts as a catalyst

Enzymes are proteins that act as biological catalysts by accelerating chemical reactions. The molecules upon which enzymes may act are called substrates, and the enzyme converts the substrates into different molecules known as products. Almost all metabolic processes in the cell need enzyme catalysis in order to occur at rates fast enough to sustain life. Metabolic pathways depend upon enzymes to catalyze individual steps. The study of enzymes is called enzymology and the field of pseudoenzyme analysis recognizes that during evolution, some enzymes have lost the ability to carry out biological catalysis, which is often reflected in their amino acid sequences and unusual 'pseudocatalytic' properties.

<span class="mw-page-title-main">Protein kinase</span> Enzyme that adds phosphate groups to other proteins

A protein kinase is a kinase which selectively modifies other proteins by covalently adding phosphates to them (phosphorylation) as opposed to kinases which modify lipids, carbohydrates, or other molecules. Phosphorylation usually results in a functional change of the target protein (substrate) by changing enzyme activity, cellular location, or association with other proteins. The human genome contains about 500 protein kinase genes and they constitute about 2% of all human genes. There are two main types of protein kinase. The great majority are serine/threonine kinases, which phosphorylate the hydroxyl groups of serines and threonines in their targets. Most of the others are tyrosine kinases, although additional types exist. Protein kinases are also found in bacteria and plants. Up to 30% of all human proteins may be modified by kinase activity, and kinases are known to regulate the majority of cellular pathways, especially those involved in signal transduction.

<span class="mw-page-title-main">Tyrosine kinase</span> Class hi residues

A tyrosine kinase is an enzyme that can transfer a phosphate group from ATP to the tyrosine residues of specific proteins inside a cell. It functions as an "on" or "off" switch in many cellular functions.

<span class="mw-page-title-main">Allosteric regulation</span> Regulation of enzyme activity

In biochemistry, allosteric regulation is the regulation of an enzyme by binding an effector molecule at a site other than the enzyme's active site.

<span class="mw-page-title-main">Active site</span> Active region of an enzyme

In biology and biochemistry, the active site is the region of an enzyme where substrate molecules bind and undergo a chemical reaction. The active site consists of amino acid residues that form temporary bonds with the substrate, the binding site, and residues that catalyse a reaction of that substrate, the catalytic site. Although the active site occupies only ~10–20% of the volume of an enzyme, it is the most important part as it directly catalyzes the chemical reaction. It usually consists of three to four amino acids, while other amino acids within the protein are required to maintain the tertiary structure of the enzymes.

<span class="mw-page-title-main">Tumor necrosis factor</span> Protein

Tumor necrosis factor is an adipokine and a cytokine. TNF is a member of the TNF superfamily, which consists of various transmembrane proteins with a homologous TNF domain.

<span class="mw-page-title-main">Binding site</span> Molecule-specific coordinate bonding area in biological systems

In biochemistry and molecular biology, a binding site is a region on a macromolecule such as a protein that binds to another molecule with specificity. The binding partner of the macromolecule is often referred to as a ligand. Ligands may include other proteins, enzyme substrates, second messengers, hormones, or allosteric modulators. The binding event is often, but not always, accompanied by a conformational change that alters the protein's function. Binding to protein binding sites is most often reversible, but can also be covalent reversible or irreversible.

<span class="mw-page-title-main">Docking (molecular)</span> Prediction method in molecular modeling

In the field of molecular modeling, docking is a method which predicts the preferred orientation of one molecule to a second when a ligand and a target are bound to each other to form a stable complex. Knowledge of the preferred orientation in turn may be used to predict the strength of association or binding affinity between two molecules using, for example, scoring functions.

Macromolecular docking is the computational modelling of the quaternary structure of complexes formed by two or more interacting biological macromolecules. Protein–protein complexes are the most commonly attempted targets of such modelling, followed by protein–nucleic acid complexes.

<span class="mw-page-title-main">Waterfowl hunting</span> Practice of hunting waterfowl for food and sport

Waterfowl hunting is the practice of hunting aquatic birds such as ducks, geese and other waterfowls or shorebirds for food and sport.

<span class="mw-page-title-main">Enzyme inhibitor</span> Molecule that blocks enzyme activity

An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity. Enzymes are proteins that speed up chemical reactions necessary for life, in which substrate molecules are converted into products. An enzyme facilitates a specific chemical reaction by binding the substrate to its active site, a specialized area on the enzyme that accelerates the most difficult step of the reaction.

<span class="mw-page-title-main">Receptor tyrosine kinase</span> Class of enzymes

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. Of the 90 unique tyrosine kinase genes identified in the human genome, 58 encode receptor tyrosine kinase proteins. Receptor tyrosine kinases have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Mutations in receptor tyrosine kinases lead to activation of a series of signalling cascades which have numerous effects on protein expression. Receptor tyrosine kinases are part of the larger family of protein tyrosine kinases, encompassing the receptor tyrosine kinase proteins which contain a transmembrane domain, as well as the non-receptor tyrosine kinases which do not possess transmembrane domains.

<span class="mw-page-title-main">Serine/threonine-specific protein kinase</span> Class of protein kinase enzymes

A serine/threonine protein kinase is a kinase enzyme, in particular a protein kinase, that phosphorylates the OH group of the amino-acid residues serine or threonine, which have similar side chains. At least 350 of the 500+ human protein kinases are serine/threonine kinases (STK).

<span class="mw-page-title-main">VEGF receptor</span> Protein family

VEGF receptors (VEGFRs) are receptors for vascular endothelial growth factor (VEGF). There are three main subtypes of VEGFR, numbered 1, 2 and 3. Depending on alternative splicing, they may be membrane-bound (mbVEGFR) or soluble (sVEGFR).

<span class="mw-page-title-main">Carboxypeptidase A</span>

Carboxypeptidase A usually refers to the pancreatic exopeptidase that hydrolyzes peptide bonds of C-terminal residues with aromatic or aliphatic side-chains. Most scientists in the field now refer to this enzyme as CPA1, and to a related pancreatic carboxypeptidase as CPA2.

<span class="mw-page-title-main">Duck decoy (structure)</span> Device to capture wild ducks or other species of waterfowl

A duck decoy is a device to capture wild ducks or other species of waterfowl. Decoys had an advantage over hunting ducks with shotguns as the duck meat did not contain lead shot. Consequently, a higher price could be charged for it.

Duck decoy is an ambiguous term which may be applied to:

<span class="mw-page-title-main">Duck decoy (model)</span> Man-made object resembling a real duck

A duck decoy is a man-made object resembling a real duck. Duck decoys are sometimes used in waterfowl hunting to attract real ducks.

Many major physiological processes depend on regulation of proteolytic enzyme activity and there can be dramatic consequences when equilibrium between an enzyme and its substrates is disturbed. In this prospective, the discovery of small-molecule ligands, like protease inhibitors, that can modulate catalytic activities has an enormous therapeutic effect. Hence, inhibition of the HIV protease is one of the most important approaches for the therapeutic intervention in HIV infection and their development is regarded as major success of structure-based drug design. They are highly effective against HIV and have, since the 1990s, been a key component of anti-retroviral therapies for HIV/AIDS.

VEGFR-2 inhibitor, also known as kinase insert domain receptor(KDR) inhibitor, are tyrosine kinase receptor inhibitors that reduce angiogenesis or lymphangiogenesis, leading to anticancer activity. Generally they are small, synthesised molecules that bind competitively to the ATP-site of the tyrosine kinase domain. VEGFR-2 selective inhibitor can interrupt multiple signaling pathways involved in tumor, including proliferation, metastasis and angiogenesis.

References

  1. Cresswell, Julia (2021). Oxford Dictionary of Word Origins. Oxford University Press. ISBN   978-0192639370.
  2. Wedgwood, Hensleigh (1855). "On False Etymologies". Transactions of the Philological Society (6): 71.
  3. Frangoulis, George (2014). Ducks and Decoys. tuscaloosa, Alabama: The Farmstead Press. ISBN   978-1-312-60897-9.
  4. "To tune of $1.13m, decoys are the real thing". The Boston Globe. 2007-09-21. Retrieved 2007-09-21.
  5. "Four decoy IEDs found in Port Said polling stations - Egypt Independent". 25 May 2014.
  6. Article title Archived 2022-09-30 at the Wayback Machine [ bare URL PDF ]
  7. "In Battle, Hunches Prove to Be Valuable". The New York Times. 28 July 2009.
  8. ""One enemy TTP is to set decoy IEDs in order to observe the immediate reactions of coalition forces. By studying our tactics they can increase the lethality of their attacks, like setting up mortars and rockets on the kill zone or safe area." (PDF)" (PDF). Retrieved Apr 12, 2019.
  9. James H. Lebovic (2010). The Limits of U.S. Military Capability: Lessons from Vietnam and Iraq. JHU Press. p. 62. ISBN   978-0-8018-9750-4.
  10. Bonnie Malkin in Sydney (6 September 2011). "Video: Man takes female hostage in Sydney office bomb siege - Telegraph". Telegraph.co.uk. Archived from the original on 6 September 2011.
  11. "We're for Sydney". Daily Telegraph. Retrieved 2019-04-12.
  12. "How Sydney siege gunman tricked police into thinking there was a bomb in his backpack". The Sydney Morning Herald. 17 December 2014.
  13. 1 2 Hugo H. Marti (2013). Vascular Endothelial Growth Factor. Landes Bioscience.
  14. Zalevsky J, Secher T, Ezhevsky SA, et al. (August 2007). "Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection". J. Immunol. 179 (3): 1872–83. doi: 10.4049/jimmunol.179.3.1872 . PMID   17641054.